DK2464384T3 - Salt af et fotosensibiliserende stof til anvendelse i fotokemisk internalisering - Google Patents
Salt af et fotosensibiliserende stof til anvendelse i fotokemisk internalisering Download PDFInfo
- Publication number
- DK2464384T3 DK2464384T3 DK10747249.0T DK10747249T DK2464384T3 DK 2464384 T3 DK2464384 T3 DK 2464384T3 DK 10747249 T DK10747249 T DK 10747249T DK 2464384 T3 DK2464384 T3 DK 2464384T3
- Authority
- DK
- Denmark
- Prior art keywords
- salt
- pharmaceutically acceptable
- therapeutic agent
- amphiphilic
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (15)
- SALT AF ET FOTOSENSIBILISERENDE STOF TIL ANVENDELSE I FOTOKEMISK INTERNALISERING1. Farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stof til anvendelse i en fremgangsmåde til fotokemisk internalisering, hvor saltet er bis(monoethanolamin) saltet af meso-tetraphenyl chlorin disulphonat (TPCS2a).
- 2. Bis(monoethanolamin) salt af meso-tetraphenyl chlorin disulphonate (TPCS2a).
- 3. Farmaceutisk sammensætning omfattende et salt ifølge krav 2, sammen med mindst en farmaceutisk acceptabel bærer eller excipiens.
- 4. Produkt omfattende et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stofsom defineret i krav 1, sammen med et terapeutisk stof til samtidig, separat eller sekventiel anvendelse i en fremgangsmåde til fotokemisk internalisering.
- 5. Kit til anvendelse i en fremgangsmåde til fotokemisk internalisering omfattende: (a) en første beholder indeholdende et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stofsom defineret i krav 1; (b) en anden beholder indeholdende et terapeutisk stof; og (c) hvor saltet er i faststofform, en tredje beholder indeholdende en vandig opløsning til at opløse saltet før anvendelse.
- 6. Farmaceutisk sammensætning omfattende et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stof som defineret i krav 1, sammen med et terapeutisk stof.
- 7. Farmaceutisk sammensætning omfattende et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stof som defineret i krav 1, sammen med et terapeutisk stof, til anvendelse i terapi.
- 8. Farmaceutisk sammensætning ifølge krav 7 til anvendelse i kræft-, gen- eller oligonukleotid-terapi.
- 9. Farmaceutisk sammensætning ifølge krav 7 til anvendelse i siRNA terapi.
- 10. Anvendelse af et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stof som defineret i krav 1 og/eller et terapeutisk stof til fremstilling af et medikament til anvendelse i terapi i hvilken saltet af det fotosensibiliserende stof og det terapeutiske stof enten separat, samtidigt eller sekventielt bringes i kontakt med celler eller væv fra en patient og cellerne eller vævene bestråles med lys med en bølgelængde effektiv til at aktivere det fotosensibiliserende stof.
- 11. Anvendelse ifølge krav 10, hvor terapien er kræft-, gen- eller oligonukleotid-terapi.
- 12. Anvendelse ifølge krav 10, hvor terapien er siRNA terapi.
- 13. Anvendelse af et farmaceutisk acceptabelt salt af et amfifilt fotosensibiliserende stof som defineret i krav 1 til fremstillingen af et terapeutisk stof til anvendelse i en fremgangsmåde til fotokemisk internalisering.
- 14. Produkt, kit, sammensætning eller anvendelse ifølge et hvilket som helst af kravene 4 til 10, hvor det terapeutiske stof er bleomycin.
- 15. Produkt, kit, sammensætning eller anvendelse ifølge et hvilket som helst af kravene 4 til 10, hvor det terapeutiske stof omfatter en vaccine komponent.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0914287.8A GB0914287D0 (en) | 2009-08-14 | 2009-08-14 | Compositions |
| PCT/GB2010/001547 WO2011018635A2 (en) | 2009-08-14 | 2010-08-16 | Photosensitizing compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2464384T3 true DK2464384T3 (da) | 2017-01-23 |
Family
ID=41171444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10747249.0T DK2464384T3 (da) | 2009-08-14 | 2010-08-16 | Salt af et fotosensibiliserende stof til anvendelse i fotokemisk internalisering |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9026203B2 (da) |
| EP (1) | EP2464384B1 (da) |
| JP (1) | JP5946407B2 (da) |
| KR (1) | KR101795362B1 (da) |
| CN (1) | CN102648004B (da) |
| AU (1) | AU2010283565B2 (da) |
| BR (1) | BR112012003283B1 (da) |
| CA (1) | CA2771021C (da) |
| DK (1) | DK2464384T3 (da) |
| ES (1) | ES2610143T3 (da) |
| GB (1) | GB0914287D0 (da) |
| HR (1) | HRP20161712T1 (da) |
| LT (1) | LT2464384T (da) |
| ME (1) | ME02616B (da) |
| MX (1) | MX337481B (da) |
| NZ (1) | NZ598380A (da) |
| PL (1) | PL2464384T3 (da) |
| PT (1) | PT2464384T (da) |
| RS (1) | RS55530B1 (da) |
| RU (1) | RU2574019C2 (da) |
| SG (1) | SG178420A1 (da) |
| SI (1) | SI2464384T1 (da) |
| WO (1) | WO2011018635A2 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0914287D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Compositions |
| GB0914286D0 (en) * | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
| WO2013009701A2 (en) | 2011-07-08 | 2013-01-17 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| GB201208548D0 (en) | 2012-05-15 | 2012-06-27 | Pci Biotech As | Compound and method |
| WO2014179760A1 (en) | 2013-05-03 | 2014-11-06 | The Regents Of The University Of California | Cyclic di-nucleotide induction of type i interferon |
| AU2014314149B2 (en) * | 2013-08-28 | 2019-12-19 | Pci Biotech As | Compound and method for vaccination and immunisation |
| CN110731961A (zh) | 2014-10-14 | 2020-01-31 | 芝加哥大学 | 金属有机框架、药物制剂及其在制备药物中的用途 |
| US10806694B2 (en) | 2014-10-14 | 2020-10-20 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof |
| GB201503776D0 (en) | 2015-03-05 | 2015-04-22 | Pci Biotech As | Compound and method |
| WO2017057784A1 (ko) * | 2015-09-30 | 2017-04-06 | (주)나노팜 | 여드름 피부개선을 위한 광민감성 물질을 함유한 건식다중캡슐형 조성물 및 그의 제조방법 |
| EP3439666A4 (en) | 2016-05-20 | 2019-12-11 | The University of Chicago | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF |
| ES2841941T3 (es) | 2016-10-14 | 2021-07-12 | Pci Biotech As | Tratamiento del colangiocarcinoma a través de la internalización fotoquímica de gemcitabina inducida por TPCS2a |
| EP3638367A4 (en) | 2017-08-02 | 2021-07-21 | The University of Chicago | NANOMETRIC ORGANOMETALLIC AND NANOPLAQUE ORGANOMETALLIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION OF THESE |
| CN107722075A (zh) * | 2017-10-09 | 2018-02-23 | 大连理工大学 | 一类二氢卟吩葡萄糖苷类化合物及其制备方法与应用 |
| GB201718631D0 (en) | 2017-11-10 | 2017-12-27 | Pci Biotech As | Method |
| RU2720799C1 (ru) * | 2019-07-03 | 2020-05-13 | Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" | Способ определения фракционного состава сульфированного фталоцианина алюминия |
| RU2757936C1 (ru) * | 2021-03-12 | 2021-10-25 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития хронической истинной экземы на основе молекулярно-генетических данных |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582831A (en) * | 1984-11-16 | 1986-04-15 | Pfizer Inc. | Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor |
| JPH0753861B2 (ja) * | 1985-04-15 | 1995-06-07 | 味の素株式会社 | 紫外線吸収剤 |
| US5284647A (en) | 1988-03-18 | 1994-02-08 | Schering Aktiengesellschaft | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them |
| US5292516A (en) | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
| US5346703A (en) | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| IT1254045B (it) * | 1991-12-31 | 1995-09-06 | Lifegroup Spa | Derivati idrosolubili della biotina e relative composizioni terapeutiche |
| US5389681A (en) | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
| FR2700543B1 (fr) * | 1993-01-15 | 1995-03-17 | Synthelabo | Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique. |
| DE4305523A1 (de) | 1993-02-17 | 1994-08-18 | Diagnostikforschung Inst | Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US6540981B2 (en) | 1997-12-04 | 2003-04-01 | Amersham Health As | Light imaging contrast agents |
| US6992107B1 (en) | 1995-03-10 | 2006-01-31 | Photocure Asa | Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy |
| DE69817529T2 (de) | 1998-02-19 | 2004-06-24 | Microflow Engineering S.A. | Vorrichtung und Gerät zur intrakavitären Wirkstofffreigabe während videounterstützter Chirurgie oder anderer endoskopischer Verfahren |
| GB9905911D0 (en) | 1999-03-15 | 1999-05-05 | Photocure As | Method |
| US6398748B1 (en) | 1999-03-16 | 2002-06-04 | Robert B. Wilson | Splint bandage and method |
| US6570013B2 (en) * | 2000-02-16 | 2003-05-27 | Pfizer Inc | Salts of zopolrestat |
| PT1346059E (pt) | 2000-11-29 | 2012-06-01 | Pci Biotech As | Internalização fotoquímica para distribuição de moléculas no citosol |
| EP1339862B1 (en) | 2000-11-29 | 2014-01-08 | PCI Biotech AS | Photochemical internalization for virus-mediated molecule delivery into the cytosol |
| GB0118251D0 (en) | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
| GB0121023D0 (en) * | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
| NZ543565A (en) | 2003-05-14 | 2008-12-24 | Univ Sherbrooke | Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| GB0415263D0 (en) | 2004-07-07 | 2004-08-11 | Norwegian Radium Hospital Res | Method |
| GB2420784A (en) | 2004-11-25 | 2006-06-07 | Pci Biotech As | Phototherapeutic amphiphilic phthalocyanine-based compounds where 1 peripheral ring system is more hydrophilic & has more hydrophilic groups than the other 3 |
| GB0514743D0 (en) * | 2005-07-19 | 2005-08-24 | Astrazeneca Ab | Salt |
| JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| GB0605743D0 (en) * | 2006-03-22 | 2006-05-03 | Oxagen Ltd | Salts with CRTH2 antagonist activity |
| JP2008095050A (ja) | 2006-10-16 | 2008-04-24 | Hidetoshi Tsuchida | アルブミン−金属ポルフィリン複合体および光増感剤 |
| GB0811955D0 (en) | 2008-06-30 | 2008-07-30 | Pci Biotech As | Method |
| GB0914286D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
| GB0914287D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Compositions |
-
2009
- 2009-08-14 GB GBGB0914287.8A patent/GB0914287D0/en not_active Ceased
-
2010
- 2010-08-16 SI SI201031359A patent/SI2464384T1/sl unknown
- 2010-08-16 EP EP10747249.0A patent/EP2464384B1/en active Active
- 2010-08-16 JP JP2012524278A patent/JP5946407B2/ja not_active Expired - Fee Related
- 2010-08-16 RU RU2012109559/15A patent/RU2574019C2/ru active
- 2010-08-16 AU AU2010283565A patent/AU2010283565B2/en not_active Ceased
- 2010-08-16 PL PL10747249T patent/PL2464384T3/pl unknown
- 2010-08-16 DK DK10747249.0T patent/DK2464384T3/da active
- 2010-08-16 NZ NZ598380A patent/NZ598380A/en not_active IP Right Cessation
- 2010-08-16 WO PCT/GB2010/001547 patent/WO2011018635A2/en not_active Ceased
- 2010-08-16 CA CA2771021A patent/CA2771021C/en active Active
- 2010-08-16 US US13/390,404 patent/US9026203B2/en active Active
- 2010-08-16 BR BR112012003283-6A patent/BR112012003283B1/pt active IP Right Grant
- 2010-08-16 LT LTEP10747249.0T patent/LT2464384T/lt unknown
- 2010-08-16 SG SG2012010385A patent/SG178420A1/en unknown
- 2010-08-16 CN CN201080046459.5A patent/CN102648004B/zh active Active
- 2010-08-16 KR KR1020127006572A patent/KR101795362B1/ko active Active
- 2010-08-16 RS RS20161158A patent/RS55530B1/sr unknown
- 2010-08-16 PT PT107472490T patent/PT2464384T/pt unknown
- 2010-08-16 HR HRP20161712TT patent/HRP20161712T1/hr unknown
- 2010-08-16 MX MX2012001953A patent/MX337481B/es active IP Right Grant
- 2010-08-16 ES ES10747249.0T patent/ES2610143T3/es active Active
- 2010-08-16 ME MEP-2016-294A patent/ME02616B/me unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2464384T3 (da) | Salt af et fotosensibiliserende stof til anvendelse i fotokemisk internalisering | |
| US20120253264A1 (en) | Photochemical internalization method | |
| US8096419B2 (en) | Compound | |
| Moret et al. | Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra (hydroxyphenyl)-chlorin (m-THPC) | |
| Enzian et al. | Optically controlled drug release from light-sensitive liposomes with the new photosensitizer 5, 10-DiOH | |
| Shan et al. | Rational design of virus-like particles for nanomedicine | |
| Saad et al. | Spotlight on photoactivatable liposomes beyond drug delivery: an enabler of multitargeting of molecular pathways | |
| CN110856750A (zh) | pH敏感缀合物、胶束及其制备方法和用途 | |
| CN115785218A (zh) | 肿瘤靶向光敏剂嵌合肽及其应用 | |
| AU2002313562C1 (en) | Compound | |
| Dey et al. | Actively targeted nanoparticles in photodynamic therapy | |
| AU2002313562A1 (en) | Compound | |
| HK1060974B (en) | Sulfonated chlorines as photosensitizer |